These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7470623)

  • 1. Procoagulant activity of sarcoma sublines with different metastatic potential.
    Colucci M; Giavazzi R; Alessandri G; Semeraro N; Mantovani A; Donati MB
    Blood; 1981 Apr; 57(4):733-5. PubMed ID: 7470623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour sublines with different metastatic capacity induce similar blood coagulation changes in the host.
    Delaini F; Giavazzi R; De Bellis Vitti G; Alessandri G; Mantovani A; Donati MB
    Br J Cancer; 1981 Jan; 43(1):100-4. PubMed ID: 7459231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between cellular procoagulant activity and metastatic capacity of B16 mouse melanoma variants.
    Gilbert LC; Gordon SG
    Cancer Res; 1983 Feb; 43(2):536-40. PubMed ID: 6848176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency.
    Colucci M; Delaini F; de Bellis Vitti G; Locati D; Poggi A; Semeraro N; Donati MB
    Biochem Pharmacol; 1983 Jun; 32(11):1689-91. PubMed ID: 6870908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proaggregatory and procoagulant properties of three murine mammary gland tumor cell lines with different metastatic capabilities.
    Pasqualini ME; Ruiz Moreno L; Muñoz SE; Eynard AR
    Exp Toxicol Pathol; 1997 Dec; 49(5):403-7. PubMed ID: 9455689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to warfarin to affect the tissue factor activity and the metastatic potential of murine fibrosarcoma cells.
    Lorenzet R; Bottazzi B; Locati D; Colucci M; Mantovani A; Semeraro N; Donati MB
    Eur J Cancer Clin Oncol; 1985 Feb; 21(2):263-5. PubMed ID: 3987761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
    Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procoagulant activity in cancer cells is dependent on tissue factor expression.
    Hu T; Bach RR; Horton R; Konigsberg WH; Todd MB
    Oncol Res; 1994; 6(7):321-7. PubMed ID: 7865907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE; Fidler IJ
    J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboplastin release, but not content, correlates with spontaneous metastasis of cancer cells.
    Grimstad IA; Prydz H
    Int J Cancer; 1988 Mar; 41(3):427-31. PubMed ID: 3346108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
    Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
    Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator activity of metastatic variants from a murine fibrosarcoma; effect of thrombin in vitro.
    Coen D; Bottazzi B; Bini A; Conforti MG; Mantovani A; Mussoni L; Donati MB
    Int J Cancer; 1983 Jul; 32(1):67-70. PubMed ID: 6683249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum laminin and type IV collagen levels for metastasis in murine RCT sarcoma.
    Matsui H; Yudoh K
    Tumour Biol; 1996; 17(3):125-32. PubMed ID: 8638087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells.
    Al Saleh HA; Haas-Neill S; Al-Hashimi A; Kapoor A; Shayegan B; Austin RC; Al-Nedawi K
    Prostate; 2018 Sep; 78(13):953-961. PubMed ID: 29761522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo.
    Amirkhosravi M; Francis JL
    Br J Haematol; 1993 Dec; 85(4):736-44. PubMed ID: 7918038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amidolytic assay for procoagulant activity of lymphoid and tumor cells.
    Lando PA; Biazak CE; Edgington TS
    J Immunol Methods; 1986 May; 89(1):131-9. PubMed ID: 3701069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procoagulant activity of rabbit alveolar macrophages.
    Sitrin RG; Kaltreider HB; Ansfield MJ; Webster RO
    Am Rev Respir Dis; 1983 Aug; 128(2):282-7. PubMed ID: 6349442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant activity of macrophages associated with different murine neoplasms.
    Guarini A; Acero R; Alessio G; Donati MB; Semeraro N; Mantovani A
    Int J Cancer; 1984 Oct; 34(4):581-6. PubMed ID: 6386701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of a herpesvirus-transformed hamster cell line: immunogenicity of sublines of high and low metastatic potential.
    Teale DM; Rees RC; Clark A; Potter CW
    Int J Cancer; 1984 May; 33(5):701-8. PubMed ID: 6724744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.